Study Finds Cannabis Knowledge Gaps Among Thai Border Patients
A 2025 study reveals significant cannabis knowledge public health education gaps among patients near the Thai-Cambodian border. Over 60% could not identify safe uses or side effects of cannabis despite legalization. This highlights urgent needs for…
Canada’s Cannabis Safety Surveillance System: What Six Years of Adverse Reaction Reports Reveal
Cannabis safety pharmacovigilance in Canada from 2018 to 2024 highlights important patterns in adverse reaction reports. Most reports involve older adults using cannabis medically, with extracts frequently implicated. This surveillance data provides…
Six Years of Legal Cannabis in Canada: What Adverse Event Reports Reveal—and What They Can’t
This analysis of cannabis adverse reactions vigilance in Canada covers 698 reports from 2018 to 2024. Most cases involved cannabis extracts and were serious but only possibly linked to cannabis. The data highlight the need for structured monitoring of…
Understanding THC Safety: Insights Beyond Social Media Headlines
THC safety is a critical topic in cannabis clinical guidelines. Emerging research highlights the need for careful risk assessment. Clinicians must rely on peer-reviewed evidence rather than social media claims.
Zurich’s Cannabis Trial Extension Highlights Swiss Access Models
Switzerland cannabis access models are evolving with Zurich's cannabis trial extension. This trial demonstrates promising safety and efficacy outcomes. The extension highlights important clinical implications for medical cannabis programs.
Not your parents’ cannabis: Legalization lights up innovation—but not clinical research
The cannabis clinical research gap widens as legalization fuels rapid product innovation without matching clinical trials. Patients access potent, diverse cannabis products, but clinicians lack robust evidence to guide safe use. This gap challenges…
THC Linked to Creation of False Memories and Difficulty With Memory Tasks
THC memory impairment effects include the creation of false memories and difficulty with memory tasks. These cognitive impacts are important for clinicians to consider when advising patients. Understanding these effects helps improve patient safety and…
Exploring Endocannabinoid System and Adolescent Psychiatric Risk
Endocannabinoid system adolescent psychiatric risk is a critical area of study linked to cannabis use in teens. Research shows increased risk of psychotic, bipolar, depressive, and anxiety disorders. Understanding this risk helps guide clinical practice…
Review of Cannabinoid Clinical Trials in Mental Health and Substance Use Treatment
Cannabinoid clinical trials mental health substance use treatment research remains limited and inconclusive. Current randomized controlled trials have not firmly established cannabinoids as effective or safe primary treatments. Clinicians should…
Man Arrested After 2-Year-Old Overdoses on THC Gummies
Pediatric THC toxicity emergency care is critical due to rising accidental ingestions of THC gummies by young children. This case highlights the need for secure cannabis storage in homes. Clinicians must counsel patients on preventing pediatric cannabis…